Furthermore, based upon binding affinity and a molecular docking examination, we show for the first time, to our knowledge, that isorhamnetin can bind TLR4/MD-2 directly, thus preventing the activation of the TLR4 cascade, which is responsible for sepsis progression. This evidence concerns the gene TLR4 and Sepsis.